Comparison of standard mismatch repair deficiency and microsatellite instability tests in a large cancer series

The tumor-agnostic indication of immune checkpoint inhibitors to treat cancers with mismatch repair deficiency (dMMR)/microsatellite instability (MSI) increased the demand for such tests beyond Lynch syndrome....

Source: Journal of Translational Medicine - February 13, 2024 Category: Research Authors: Maja L. N ádorvári, István Kenessey, András Kiss, Tamás Barbai, Janina Kulka, Erzsébet Rásó and József Tímár Tags: Research Source Type: research